ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 5 analysts with an average price target of $66.63. This is a potential upside of $52.43 (369.23%) from yesterday's end of day stock price of $14.2.

Atara Biotherapeutics's activity chart (see below) currently has 80 price targets and 87 ratings on display. The stock rating distribution of ATRA is 57.14% BUY and 42.86% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.08% with an average time for these price targets to be met of 68.9 days.

Highest price target for ATRA is $17, Lowest price target is $5, average price target is $11.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 11-Mar-2025. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 4 are a BUY (57.14%), 3 are a HOLD (42.86%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$17

$1.9 (12.58%)

$17

8 months 23 days ago
(11-Mar-2025)

2/6 (33.33%)

$10.39 (157.19%)

59

Hold

10 months 6 days ago
(28-Jan-2025)

1/4 (25%)

$376.5 (88.90%)

175

Hold

$5

$-10.1 (-66.89%)

$10

10 months 13 days ago
(21-Jan-2025)

2/8 (25%)

$-1.05 (-17.36%)

33

Buy

$25

$9.9 (65.56%)

1 years 3 months 18 days ago
(16-Aug-2024)

0/4 (0%)

$17.99 (256.63%)

Sell

$35

$19.9 (131.79%)

$75

2 years 3 months 13 days ago
(21-Aug-2023)

13/13 (100%)

$-0.25 (-0.71%)

298

Show more analysts

Please expand the browser size to see the chart

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 68.9 days on average for the stock forecasts to be realized with a an average price target met ratio 37.08

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

John Newman works at CANACCORD and has 5 price targets and 5 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $609.9

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Benjamin Burnett with lowest potential downside - -$10.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?